| Mercy Hospice 1570 West Battlefield, Suite 110, Springfield, MO, 65807 | |
| (417) 820-7550 |
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ("FDA") has publically announced the scheduling of an April 22, 2010 Advisory Committee meeting to discuss the New Drug Application ("NDA") for Acurox® (oxycodone HCl and niacin) Tablets and the results of studies evaluating the addition of niacin for the purpose of reducing the misuse of oxycodone.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
A survey released today from Plan for Your Health, the health benefits public education program launched in September 2004 by Aetna (NYSE: AET) and the Financial Planning Association (FPA), found that less than 20 percent of insured adults surveyed consider themselves very knowledgeable about their health benefits plan.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
› Verified 7 days ago
| Name | Mercy Hospice |
|---|---|
| Location | 1570 West Battlefield, Suite 110, Springfield, Missouri |
| Hospice ID | 261513 |
| Category | Part of a hospital |
| Ownership Type | Voluntary Non-profit - Church |
| Profit Type | NON-PROFIT |
| SSA county code | 380 |
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ("FDA") has publically announced the scheduling of an April 22, 2010 Advisory Committee meeting to discuss the New Drug Application ("NDA") for Acurox® (oxycodone HCl and niacin) Tablets and the results of studies evaluating the addition of niacin for the purpose of reducing the misuse of oxycodone.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
A survey released today from Plan for Your Health, the health benefits public education program launched in September 2004 by Aetna (NYSE: AET) and the Financial Planning Association (FPA), found that less than 20 percent of insured adults surveyed consider themselves very knowledgeable about their health benefits plan.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
› Verified 7 days ago
| NPI Number | 1467483347 |
| Organization Name | Mercy Hospital Springfield |
| Address | 1570 W Battlefield St Springfield, Missouri, 65807 |
| Phone Number | (417)820-7550 |
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ("FDA") has publically announced the scheduling of an April 22, 2010 Advisory Committee meeting to discuss the New Drug Application ("NDA") for Acurox® (oxycodone HCl and niacin) Tablets and the results of studies evaluating the addition of niacin for the purpose of reducing the misuse of oxycodone.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
A survey released today from Plan for Your Health, the health benefits public education program launched in September 2004 by Aetna (NYSE: AET) and the Financial Planning Association (FPA), found that less than 20 percent of insured adults surveyed consider themselves very knowledgeable about their health benefits plan.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.9 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.3 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 98.3 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 49.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 99.7 | 93.3 |
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ("FDA") has publically announced the scheduling of an April 22, 2010 Advisory Committee meeting to discuss the New Drug Application ("NDA") for Acurox® (oxycodone HCl and niacin) Tablets and the results of studies evaluating the addition of niacin for the purpose of reducing the misuse of oxycodone.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
A survey released today from Plan for Your Health, the health benefits public education program launched in September 2004 by Aetna (NYSE: AET) and the Financial Planning Association (FPA), found that less than 20 percent of insured adults surveyed consider themselves very knowledgeable about their health benefits plan.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
› Verified 7 days ago
| Home Health Aides | 4 |
| Counselors | 3.6 |
| Homemakers | 2 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 4 |
| Registered Nurses | 26 |
| Other Personnel | 8.2 |
| Total Employees | 48.8 |
|---|
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ("FDA") has publically announced the scheduling of an April 22, 2010 Advisory Committee meeting to discuss the New Drug Application ("NDA") for Acurox® (oxycodone HCl and niacin) Tablets and the results of studies evaluating the addition of niacin for the purpose of reducing the misuse of oxycodone.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
A survey released today from Plan for Your Health, the health benefits public education program launched in September 2004 by Aetna (NYSE: AET) and the Financial Planning Association (FPA), found that less than 20 percent of insured adults surveyed consider themselves very knowledgeable about their health benefits plan.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
› Verified 7 days ago
| Others | 65 |
| Total Volunteers | 65 |
|---|
News Archive
Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ("FDA") has publically announced the scheduling of an April 22, 2010 Advisory Committee meeting to discuss the New Drug Application ("NDA") for Acurox® (oxycodone HCl and niacin) Tablets and the results of studies evaluating the addition of niacin for the purpose of reducing the misuse of oxycodone.
BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage development company with key compound LT-673, an orally available poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of patients with rare, genetically defined cancers.
A survey released today from Plan for Your Health, the health benefits public education program launched in September 2004 by Aetna (NYSE: AET) and the Financial Planning Association (FPA), found that less than 20 percent of insured adults surveyed consider themselves very knowledgeable about their health benefits plan.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
› Verified 7 days ago
| Hospice Compassus- Southwest Missouri Location: 1465 E. Primrose, Springfield, Missouri, 65804 Phone: (417) 820-7550 |
| Mercy Hospice Location: 1570 West Battlefield, Suite 110, Springfield, Missouri, 65807 Phone: (417) 820-7550 |
| Regional Hospice Location: 3405 West Mount Vernon, Suite 100, Springfield, Missouri, 65802 Phone: (417) 820-7550 |
| Seasons Hospice, Inc Location: 1831 W Melville Road, Springfield, Missouri, 65803 Phone: (417) 820-7550 |